Can We Slow AI Down Without Losing?

The episode centered on a question that suddenly has unusual support across the AI industry: should frontier development slow down enough to give safety systems and institutions time to catch up? The discussion began with Dario Amodei’s “We Must Pace the Frontier” essay and the hosts’ observation that Sam Altman, Elon Musk, Demis Hassabis and Microsoft leaders had all expressed some level of agreement with its direction. The significance was not simply the proposal itself, but that executives who compete aggressively with one another appeared to acknowledge a shared risk. The group discussed recent AI security incidents, the possibility of increasingly autonomous systems causing damage at internet scale, and proposals for independent evaluators with deep access inside frontier labs. The hardest problem remained coordination. If U.S. companies slow down while China continues advancing, unilateral restraint could become strategically difficult, yet waiting for global agreement may mean never acting at all. That led into a broader debate over regulation, regulatory capture, international oversight and whether existing institutions such as consumer-protection and safety agencies provide useful models for AI governance. Brian argued that most businesses already have more AI capability than they know how to deploy, with systems, integrations, harnesses and operating practices now creating bigger bottlenecks than model intelligence itself. The group also wrestled with whether slowing frontier development could delay major medical gains, making the tradeoff more personal than a simple safety-versus-speed argument. Earlier topics included reports that OpenAI had paused new $200 Codex subscriptions, questions about whether Codex performance had changed after launch, comparisons between Codex and Claude Fable 5.1, and Abacus AI’s lower-cost Smog Flash model. The final section covered DeepMind research that helped identify a previously missed genetic variant associated with a rare epilepsy case, expert skepticism about some AI-generated bioweapon scenarios, and a closing question for the panel: if superintelligence arrives, can humans actually control it? Key Points Discussed 00:00:20 Episode Intro And Monday Check-In 00:01:33 Working Around Astra’s Five-Hour Limits 00:02:42 Using Claude Code For Estimated Taxes 00:05:05 AI Improves Detection Of Fetal Brain Anomalies 00:06:12 Abacus AI Pushes Toward Cheaper Inference 00:08:53 OpenAI Pauses New $200 Codex Subscriptions 00:10:00 Has Codex Been Nerfed Since Launch? 00:12:08 Fable 5.1 Versus Codex In Real Work 00:17:10 Anthropic’s Temporary Fable Usage Increase Ends 00:19:59 Dario Amodei Says We Must Pace The Frontier 00:20:33 Rival AI Leaders Publicly Agree With The Warning 00:23:05 Recent AI Security Incidents Become A Warning Sign 00:24:44 Could Recursive AI Cause Damage At Internet Scale? 00:25:22 The China Problem And Why Slowing Down Is So Difficult 00:27:18 Is AI Regulation Really About Regulatory Capture? 00:28:38 King Charles Brings AI Leaders Together On Safety 00:31:00 Comparing AI Risk With Nuclear And Climate Coordination 00:33:26 Who Slows Down First In A Global AI Race? 00:36:03 Should Independent Evaluators Sit Inside Frontier Labs? 00:38:12 Can Regulation Work Without Trust Between AI Companies? 00:40:43 Should Some Areas Of AI Slow While Medicine Accelerates? 00:42:07 What Existing Consumer Protection Agencies Can Teach AI 00:46:39 Businesses Already Have More AI Power Than They Can Deploy 00:50:37 Why AI Models Behave More Like Growing Systems Than Software 00:54:53 The AI Token Addiction TikTok 00:57:07 DeepMind Helps Surface A Missed Genetic Variant 01:00:11 Experts Push Back On Some AI Bioweapon Fears 01:03:28 Can You Support AI Acceleration And Regulation? 01:04:31 Can Humans Control Superintelligence? 01:05:58 Episode Wrap-Up The Daily AI Show Co Hosts: Brian Maucere, Andy Halliday, Beth Lyons, Gareth Hood.